We amplified that TAGLN2 was positively correlated with most cancer-promoting pathways, such as glycolysis, apoptosis, hypoxia, EMT, PI3K AKT MTOR signaling, and angiogenesis. This evidence concerns the gene TAGLN2 and cancer.